A study by researchers Medical University of South Carolina (MUSC) shows overcoming T-cell exhaustion could improve responses to two types of immunotherapies – anti-PD1 therapy and #CARTcelltherapy . Learn more: web.musc.edu/about/news-cen… #CancerResearch #immunotherapy

Great #EarthDay webinar today on greening research labs! Thanks to our speakers Dr. Rebecca Auer Rebecca Auer, MD & Carole Dore of The Ottawa Hospital & thanks to all who attended! If you missed it - stay tuned - in the coming days we'll post the video online. #Summit4CISpeakerSeries

Our #EarthDay #Summit4CISpeakerSeries on reducing carbon footprint in research labs is underway with #BioCanRx network researcher Dr. Rebecca Auer Rebecca Auer, MD​ & lab manager Carol​e Dore, both of the​ The Ottawa Hospital. Learn more: cancersummit.ca/summit-speaker… #CancerResearch #GreenLabs

Today is Earth Day! Join us at 2 pm ET for this free, virtual webinar on greening research labs! Register: bit.ly/3Tle4VD

Join us on Monday - Earth Day - for this free, virtual webinar about greening research labs! See below to register ⬇️

A phase II clinical trial by researchers University of Hawaii Cancer Center shows promise for maintenance therapy in aggressive #breastcancer . The trial evaluated the safety and effectiveness of pembrolizumab, an immune checkpoint inhibitor, following chemotherapy: uhcancercenter.org/about-us/newsr…

Mark Earth Day with us & our #Summit4CISpeakerSeries ! #BioCanRx network researcher Dr. Rebecca Auer Rebecca Auer, MD & lab manager Carol Dore, both of the The Ottawa Hospital, will join us to talk about reducing carbon footprint in research labs. It's free! Register: bit.ly/3Tle4VD

We are very happy to share our review about engineering CAR T cells directly in vivo.
cell.com/trends/pharmac…

Budget2024 is a big win for Canadian research. BioCanRx welcomes the announced new funding & key measures to boost research, innovation & productivity that will go a long way to driving Canadian discoveries from the bench to the bedside. canada.ca/en/department-… #CanadianResearch

#ISCT2024 brings together delegates from academia, regulatory & industry to discuss research & the greatest challenges in cell & gene therapy. #BioCanRx network researchers, HQP & CSA members receive a 15% discount. Email [email protected] for the code. isctglobal.org/isct2024/home

Congratulations Michel Sadelain! He was honored along with Carl June for their development of chimeric antigen receptor T cell immunotherapy, whereby a patient’s T cells are modified to target and kill cancer cells. @academymuseum Breakthrough #breakthrough Memorial Sloan Kettering Cancer Center

A great start to the week with photos from Camille Leahy, patient advocate and CLIC1901 clinical trial participant representing Canada, BioCanRx, BCCA, TOH, OHRI at the 2024 Breakthrough Prize celebrating the 'Stars of Science' and Canadian Michel Sadelain. Félicitations!

Dr. Michel Sadelain receives 'Oscars of Science' Breakthrough for CAR T cell therapy. Learn more in this Barron's story: barrons.com/news/french-ca… Living Drugs

Congratulations to Michel Sadelain, MD, PhD, FAACR, of Memorial Sloan Kettering Cancer Center, awarded the Gairdner Foundation International Awards today for his work on CD19-CAR T cell therapy for cancer, along with Zelig Eshhar, PhD, Weizmann Institute. #AACRFellows

At the AACR annual meeting, cancer vaccines get a reintroduction as readouts support 'path forward' for the tech. Read more in this FierceBiotech report: fiercebiotech.com/biotech/aacr-2… #AACR24 #CancerResearch

Congratulations to the 2024 Canada Gairdner Award laureates! This year’s laureates represent some of the world’s most significant biomedical and global health research & discoveries.

Find more about these incredible scientists and their award-winning research here:

Attention patient partners! Are you passionate about informing #CancerResearch in Canada? The Institute of Cancer Research is seeking a patient representative for our Institute Advisory Board.

If you are interested, e-mail us at [email protected]. Application deadline is April 25.

Our next #Summit4CISpeakerSeries is on Earth Day! We'll be joined by #BioCanRx network researcher Dr. Rebecca Auer Rebecca Auer, MD & lab manager Carol Dore - both of the The Ottawa Hospital to learn about reducing carbon footprint in research labs. Join us! Register: bit.ly/3Tle4VD

#NRCHealth , together with the BioCanRx - Canada's Immunotherapy Network Canadian-Led Immunotherapies in Cancer program, has developed a made-in-Canada CD22-CAR-T that could offer new treatment options for patients with blood cancers such as leukemia & lymphoma. ow.ly/Nlio50RaFY0

#NRCChallengeGeneTherapy

#SantéCNRC , avec le programme des immunothérapies du cancer dirigées par le Canada de BioCanRx - Canada's Immunotherapy Network, a mis au point une thérapie cellulaire CD22-CAR-T pour patients atteints de cancers du sang comme la leucémie et le lymphome. ow.ly/8Iwi50RaG1s #DéfiThérapiesGéniquesCNRC